Search results
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 5 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
Investor's Business Daily· 3 days agoTherapeutics stock also rose a fraction to close at 276.26. A Boon For Liquidia Stock The news is a...
With new Enhertu data, an ADC could overtake chemo in breast cancer
BioPharma Dive via Yahoo Finance· 4 days agoThe study hasn’t continued for long enough to clearly tell whether Enhertu extends survival. Enhertu...
Hypersensitivity Pneumonitis Patients Share Need-to-Knows
Medscape· 14 hours agoHP is caused by environmental exposure and is often incurable, and patients are challenged with...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 4 days agoHowever, no patients experienced Grade ≥3 interstitial lung disease. These safety results are in...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 3 days agoThe commonly observed side effect was peripheral sensory neuropathy. Two grade 5 adverse events...
Educational Intervention Curbs Unnecessary Inhaler Use
Medscape· 4 days agoILD patients often have symptoms that overlap with those of obstructive airways diseases, wrote...
Merus reports promising results for lung cancer antibody MCLA-129 By Investing.com
Investing.com· 3 days agoThe presentation detailed the efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific...
Judge denies United Therapeutics' attempt to block Liquidia from expanding PAH drug - Triangle...
The Business Journals· 2 days agoA federal judge on May 31 denied a motion by United Therapeutics for a preliminary injunction aimed...
Aprilyn C. Oswald Randolph
WDTV· 3 days agoAprilyn C. Oswald Randolph